New nonpeptide compound AY-0068 is a potent, selective and metabolically stable tryptase inhibitor Jan. 4, 2000
Asthma symptoms improve significantly, steroid use decreases in patients on anti-IgE therapy Dec. 28, 1999
Genome Therapeutics achieves milestone in asthma genomics alliance with Schering-Plough Dec. 23, 1999
RSS